Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 195

1.

Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children.

Ome-Kaius M, Kattenberg JH, Zaloumis S, Siba M, Kiniboro B, Jally S, Razook Z, Mantila D, Sui D, Ginny J, Rosanas-Urgell A, Karl S, Obadia T, Barry A, Rogerson SJ, Laman M, Tisch D, Felger I, Kazura JW, Mueller I, Robinson LJ.

BMC Med. 2019 Dec 9;17(1):220. doi: 10.1186/s12916-019-1456-9.

2.

Comparison of repeated doses of ivermectin versus ivermectin plus albendazole for treatment of onchocerciasis - a randomized open-label clinical trial.

Batsa Debrah L, Klarmann-Schulz U, Osei-Mensah J, Dubben B, Fischer K, Mubarik Y, Ayisi-Boateng NK, Ricchiuto A, Fimmers R, Konadu P, Nadal J, Gruetzmacher B, Weil G, Kazura JW, King CL, Debrah AY, Hoerauf A.

Clin Infect Dis. 2019 Sep 19. pii: ciz889. doi: 10.1093/cid/ciz889. [Epub ahead of print]

PMID:
31536624
3.

Low Levels of Human Antibodies to Gametocyte-Infected Erythrocytes Contrasts the PfEMP1-Dominant Response to Asexual Stages in P. falciparum Malaria.

Chan JA, Drew DR, Reiling L, Lisboa-Pinto A, Dinko B, Sutherland CJ, Dent AE, Chelimo K, Kazura JW, Boyle MJ, Beeson JG.

Front Immunol. 2019 Jan 14;9:3126. doi: 10.3389/fimmu.2018.03126. eCollection 2018.

4.

Volume 100 of the American Journal of Tropical Medicine and Hygiene.

Rosenthal PJ, Vinetz JM, Siegel C, Kazura JW.

Am J Trop Med Hyg. 2019 Jan;100(1):3-4. doi: 10.4269/ajtmh.18-0848. No abstract available.

5.

Spatial-temporal heterogeneity in malaria receptivity is best estimated by vector biting rates in areas nearing elimination.

Burkot TR, Bugoro H, Apairamo A, Cooper RD, Echeverry DF, Odabasi D, Beebe NW, Makuru V, Xiao H, Davidson JR, Deason NA, Reuben H, Kazura JW, Collins FH, Lobo NF, Russell TL.

Parasit Vectors. 2018 Nov 27;11(1):606. doi: 10.1186/s13071-018-3201-1.

6.

A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.

King CL, Suamani J, Sanuku N, Cheng YC, Satofan S, Mancuso B, Goss CW, Robinson LJ, Siba PM, Weil GJ, Kazura JW.

N Engl J Med. 2018 Nov 8;379(19):1801-1810. doi: 10.1056/NEJMoa1706854.

7.

Dr. Adel A. F. Mahmoud.

James S, Kazura JW, Colley D.

Am J Trop Med Hyg. 2018 Aug;99(2):255. doi: 10.4269/ajtmh.18-1941. Epub 2018 Jun 28. No abstract available.

8.

Human antibodies activate complement against Plasmodium falciparum sporozoites, and are associated with protection against malaria in children.

Kurtovic L, Behet MC, Feng G, Reiling L, Chelimo K, Dent AE, Mueller I, Kazura JW, Sauerwein RW, Fowkes FJI, Beeson JG.

BMC Med. 2018 Apr 30;16(1):61. doi: 10.1186/s12916-018-1054-2.

9.

Understanding heterogeneities in mosquito-bite exposure and infection distributions for the elimination of lymphatic filariasis.

Irvine MA, Kazura JW, Hollingsworth TD, Reimer LJ.

Proc Biol Sci. 2018 Jan 31;285(1871). pii: 20172253. doi: 10.1098/rspb.2017.2253.

10.

Cutting Edge: Plasmodium falciparum Induces Trained Innate Immunity.

Schrum JE, Crabtree JN, Dobbs KR, Kiritsy MC, Reed GW, Gazzinelli RT, Netea MG, Kazura JW, Dent AE, Fitzgerald KA, Golenbock DT.

J Immunol. 2018 Feb 15;200(4):1243-1248. doi: 10.4049/jimmunol.1701010. Epub 2018 Jan 12.

11.

Sero-catalytic and Antibody Acquisition Models to Estimate Differing Malaria Transmission Intensities in Western Kenya.

Weber GE, White MT, Babakhanyan A, Sumba PO, Vulule J, Ely D, John C, Angov E, Lanar D, Dutta S, Narum DL, Horii T, Cowman A, Beeson J, Smith J, Kazura JW, Dent AE.

Sci Rep. 2017 Dec 4;7(1):16821. doi: 10.1038/s41598-017-17084-9.

12.

Sustained Malaria Control Over an 8-Year Period in Papua New Guinea: The Challenge of Low-Density Asymptomatic Plasmodium Infections.

Koepfli C, Ome-Kaius M, Jally S, Malau E, Maripal S, Ginny J, Timinao L, Kattenberg JH, Obadia T, White M, Rarau P, Senn N, Barry AE, Kazura JW, Mueller I, Robinson LJ.

J Infect Dis. 2017 Dec 12;216(11):1434-1443. doi: 10.1093/infdis/jix507.

13.

Monocyte dysregulation and systemic inflammation during pediatric falciparum malaria.

Dobbs KR, Embury P, Vulule J, Odada PS, Rosa BA, Mitreva M, Kazura JW, Dent AE.

JCI Insight. 2017 Sep 21;2(18). pii: 95352. doi: 10.1172/jci.insight.95352. eCollection 2017 Sep 21.

14.

Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.

Chan JA, Stanisic DI, Duffy MF, Robinson LJ, Lin E, Kazura JW, King CL, Siba PM, Fowkes FJ, Mueller I, Beeson JG.

Eur J Immunol. 2017 Dec;47(12):2124-2136. doi: 10.1002/eji.201747032. Epub 2017 Sep 13.

15.

Onchocerciasis Elimination from Africa: One Step in Northern Sudan.

Kazura JW.

Am J Trop Med Hyg. 2016 Nov 2;95(5):983-984. doi: 10.4269/ajtmh.16-0684. Epub 2016 Oct 3. No abstract available.

16.

A novel approach to identifying patterns of human invasion-inhibitory antibodies guides the design of malaria vaccines incorporating polymorphic antigens.

Drew DR, Wilson DW, Elliott SR, Cross N, Terheggen U, Hodder AN, Siba PM, Chelimo K, Dent AE, Kazura JW, Mueller I, Beeson JG.

BMC Med. 2016 Sep 23;14(1):144.

17.

Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax.

Hupalo DN, Luo Z, Melnikov A, Sutton PL, Rogov P, Escalante A, Vallejo AF, Herrera S, Arévalo-Herrera M, Fan Q, Wang Y, Cui L, Lucas CM, Durand S, Sanchez JF, Baldeviano GC, Lescano AG, Laman M, Barnadas C, Barry A, Mueller I, Kazura JW, Eapen A, Kanagaraj D, Valecha N, Ferreira MU, Roobsoong W, Nguitragool W, Sattabonkot J, Gamboa D, Kosek M, Vinetz JM, González-Cerón L, Birren BW, Neafsey DE, Carlton JM.

Nat Genet. 2016 Aug;48(8):953-8. doi: 10.1038/ng.3588. Epub 2016 Jun 27.

18.

Population genomics of the filarial nematode parasite Wuchereria bancrofti from mosquitoes.

Small ST, Reimer LJ, Tisch DJ, King CL, Christensen BM, Siba PM, Kazura JW, Serre D, Zimmerman PA.

Mol Ecol. 2016 Apr;25(7):1465-77. doi: 10.1111/mec.13574. Epub 2016 Mar 15.

19.

Malaria transmission dynamics surrounding the first nationwide long-lasting insecticidal net distribution in Papua New Guinea.

Reimer LJ, Thomsen EK, Koimbu G, Keven JB, Mueller I, Siba PM, Kazura JW, Hetzel MW, Zimmerman PA.

Malar J. 2016 Jan 12;15:25. doi: 10.1186/s12936-015-1067-7.

20.

Contrasting Patterns of Serologic and Functional Antibody Dynamics to Plasmodium falciparum Antigens in a Kenyan Birth Cohort.

Dent AE, Malhotra I, Wang X, Babineau D, Yeo KT, Anderson T, Kimmel RJ, Angov E, Lanar DE, Narum D, Dutta S, Richards J, Beeson JG, Crabb BS, Cowman AF, Horii T, Muchiri E, Mungai PL, King CL, Kazura JW.

Clin Vaccine Immunol. 2015 Dec 9;23(2):104-16. doi: 10.1128/CVI.00452-15. Print 2016 Feb.

21.

More Progress in Eliminating Transmission of Onchocerca volvulus and Wuchereria bancrofti in the Americas: A Portent of Global Eradication.

Kazura JW.

Am J Trop Med Hyg. 2015 Dec;93(6):1128-1129. doi: 10.4269/ajtmh.15-0688. Epub 2015 Oct 26. No abstract available.

22.

Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.

Thomsen EK, Sanuku N, Baea M, Satofan S, Maki E, Lombore B, Schmidt MS, Siba PM, Weil GJ, Kazura JW, Fleckenstein LL, King CL.

Clin Infect Dis. 2016 Feb 1;62(3):334-341. doi: 10.1093/cid/civ882. Epub 2015 Oct 20.

PMID:
26486704
23.

Malaria Epidemiology and Control Within the International Centers of Excellence for Malaria Research.

Moss WJ, Dorsey G, Mueller I, Laufer MK, Krogstad DJ, Vinetz JM, Guzman M, Rosas-Aguirre AM, Herrera S, Arevalo-Herrera M, Chery L, Kumar A, Mohapatra PK, Ramanathapuram L, Srivastava HC, Cui L, Zhou G, Parker DM, Nankabirwa J, Kazura JW, For The International Centers Of Excellence For Malaria Research.

Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):5-15. doi: 10.4269/ajtmh.15-0006. Epub 2015 Aug 10.

24.

High Rates of Asymptomatic, Sub-microscopic Plasmodium vivax Infection and Disappearing Plasmodium falciparum Malaria in an Area of Low Transmission in Solomon Islands.

Waltmann A, Darcy AW, Harris I, Koepfli C, Lodo J, Vahi V, Piziki D, Shanks GD, Barry AE, Whittaker M, Kazura JW, Mueller I.

PLoS Negl Trop Dis. 2015 May 21;9(5):e0003758. doi: 10.1371/journal.pntd.0003758. eCollection 2015 May.

25.

Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.

Dent AE, Nakajima R, Liang L, Baum E, Moormann AM, Sumba PO, Vulule J, Babineau D, Randall A, Davies DH, Felgner PL, Kazura JW.

J Infect Dis. 2015 Nov 1;212(9):1429-38. doi: 10.1093/infdis/jiv224. Epub 2015 Apr 15. Erratum in: J Infect Dis. 2016 Jan 1;213(1):167.

26.

Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya.

LaBeaud AD, Pfeil S, Muiruri S, Dahir S, Sutherland LJ, Traylor Z, Gildengorin G, Muchiri EM, Morrill J, Peters CJ, Hise AG, Kazura JW, King CH.

PLoS Negl Trop Dis. 2015 Mar 12;9(3):e0003548. doi: 10.1371/journal.pntd.0003548. eCollection 2015 Mar.

27.

Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways.

Hise AG, Traylor Z, Hall NB, Sutherland LJ, Dahir S, Ermler ME, Muiruri S, Muchiri EM, Kazura JW, LaBeaud AD, King CH, Stein CM.

PLoS Negl Trop Dis. 2015 Mar 10;9(3):e0003584. doi: 10.1371/journal.pntd.0003584. eCollection 2015 Mar.

28.

Yaws eradication--a goal finally within reach.

Kazura JW.

N Engl J Med. 2015 Feb 19;372(8):693-5. doi: 10.1056/NEJMp1415346. No abstract available.

29.

Time-to-infection by Plasmodium falciparum is largely determined by random factors.

Pinkevych M, Chelimo K, Vulule J, Kazura JW, Moormann AM, Davenport MP.

BMC Med. 2015 Jan 30;13:19. doi: 10.1186/s12916-014-0252-9.

30.

Effect of transmission intensity and age on subclass antibody responses to Plasmodium falciparum pre-erythrocytic and blood-stage antigens.

Noland GS, Jansen P, Vulule JM, Park GS, Ondigo BN, Kazura JW, Moormann AM, John CC.

Acta Trop. 2015 Feb;142:47-56. doi: 10.1016/j.actatropica.2014.10.011. Epub 2014 Oct 24.

31.

Acquisition of antibodies against Plasmodium falciparum merozoites and malaria immunity in young children and the influence of age, force of infection, and magnitude of response.

Stanisic DI, Fowkes FJ, Koinari M, Javati S, Lin E, Kiniboro B, Richards JS, Robinson LJ, Schofield L, Kazura JW, King CL, Zimmerman P, Felger I, Siba PM, Mueller I, Beeson JG.

Infect Immun. 2015 Feb;83(2):646-60. doi: 10.1128/IAI.02398-14. Epub 2014 Nov 24.

32.

The continuing evolution of theAmerican Journal of Tropical Medicine & Hygiene.

Kazura JW.

Am J Trop Med Hyg. 2013 Dec;89(6):1037. doi: 10.4269/ajtmh.13-0642. No abstract available.

33.

Decreased growth rate of P. falciparum blood stage parasitemia with age in a holoendemic population.

Pinkevych M, Petravic J, Chelimo K, Vulule J, Kazura JW, Moormann AM, Davenport MP.

J Infect Dis. 2014 Apr 1;209(7):1136-43. doi: 10.1093/infdis/jit613. Epub 2013 Nov 21.

34.

Density-dependent blood stage Plasmodium falciparum suppresses malaria super-infection in a malaria holoendemic population.

Pinkevych M, Petravic J, Chelimo K, Vulule J, Kazura JW, Moormann AM, Davenport MP.

Am J Trop Med Hyg. 2013 Nov;89(5):850-6. doi: 10.4269/ajtmh.13-0049. Epub 2013 Sep 9.

35.

Insecticidal bed nets and filariasis transmission in Papua New Guinea.

Reimer LJ, Thomsen EK, Tisch DJ, Henry-Halldin CN, Zimmerman PA, Baea ME, Dagoro H, Susapu M, Hetzel MW, Bockarie MJ, Michael E, Siba PM, Kazura JW.

N Engl J Med. 2013 Aug 22;369(8):745-53. doi: 10.1056/NEJMoa1207594.

36.

Population genetics of the filarial worm wuchereria bancrofti in a post-treatment region of Papua New Guinea: insights into diversity and life history.

Small ST, Ramesh A, Bun K, Reimer L, Thomsen E, Baea M, Bockarie MJ, Siba P, Kazura JW, Tisch DJ, Zimmerman PA.

PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2308. doi: 10.1371/journal.pntd.0002308. Print 2013.

37.

Humoral and cellular immunity to Plasmodium falciparum merozoite surface protein 1 and protection from infection with blood-stage parasites.

Moormann AM, Sumba PO, Chelimo K, Fang H, Tisch DJ, Dent AE, John CC, Long CA, Vulule J, Kazura JW.

J Infect Dis. 2013 Jul;208(1):149-58. doi: 10.1093/infdis/jit134. Epub 2013 Mar 28.

38.

The dynamics of naturally acquired immunity to Plasmodium falciparum infection.

Pinkevych M, Petravic J, Chelimo K, Kazura JW, Moormann AM, Davenport MP.

PLoS Comput Biol. 2012;8(10):e1002729. doi: 10.1371/journal.pcbi.1002729. Epub 2012 Oct 18.

39.

Broadly reactive antibodies specific for Plasmodium falciparum MSP-1(19) are associated with the protection of naturally exposed children against infection.

Dent AE, Moormann AM, Yohn CT, Kimmel RJ, Sumba PO, Vulule J, Long CA, Narum DL, Crabb BS, Kazura JW, Tisch DJ.

Malar J. 2012 Aug 21;11:287. doi: 10.1186/1475-2875-11-287.

40.

Toll-like receptor polymorphisms and cerebral malaria: TLR2 Δ22 polymorphism is associated with protection from cerebral malaria in a case control study.

Greene JA, Sam-Agudu N, John CC, Opoka RO, Zimmerman PA, Kazura JW.

Malar J. 2012 Feb 15;11:47. doi: 10.1186/1475-2875-11-47.

41.

The complete mitochondrial genome sequence of the filarial nematode Wuchereria bancrofti from three geographic isolates provides evidence of complex demographic history.

Ramesh A, Small ST, Kloos ZA, Kazura JW, Nutman TB, Serre D, Zimmerman PA.

Mol Biochem Parasitol. 2012 May;183(1):32-41. doi: 10.1016/j.molbiopara.2012.01.004. Epub 2012 Feb 1.

42.

The role of animal models for research on severe malaria.

Craig AG, Grau GE, Janse C, Kazura JW, Milner D, Barnwell JW, Turner G, Langhorne J; participants of the Hinxton Retreat meeting on Animal Models for Research on Severe Malaria.

PLoS Pathog. 2012 Feb;8(2):e1002401. doi: 10.1371/journal.ppat.1002401. Epub 2012 Feb 2. No abstract available.

43.

Multiplex assay for species identification and monitoring of insecticide resistance in Anopheles punctulatus group populations of Papua New Guinea.

Henry-Halldin CN, Nadesakumaran K, Keven JB, Zimmerman AM, Siba P, Mueller I, Hetzel MW, Kazura JW, Thomsen E, Reimer LJ, Zimmerman PA.

Am J Trop Med Hyg. 2012 Jan;86(1):140-51. doi: 10.4269/ajtmh.2012.11-0503.

44.

Age-related differences in naturally acquired T cell memory to Plasmodium falciparum merozoite surface protein 1.

Chelimo K, Embury PB, Sumba PO, Vulule J, Ofulla AV, Long C, Kazura JW, Moormann AM.

PLoS One. 2011;6(9):e24852. doi: 10.1371/journal.pone.0024852. Epub 2011 Sep 16.

45.

Research challenges and gaps in malaria knowledge in Papua New Guinea.

Kazura JW, Siba PM, Betuela I, Mueller I.

Acta Trop. 2012 Mar;121(3):274-80. doi: 10.1016/j.actatropica.2011.08.002. Epub 2011 Aug 27.

46.

Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.

McCarra MB, Ayodo G, Sumba PO, Kazura JW, Moormann AM, Narum DL, John CC.

Pediatr Infect Dis J. 2011 Dec;30(12):1037-42. doi: 10.1097/INF.0b013e31822d1451.

47.

Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.

Tisch DJ, Alexander ND, Kiniboro B, Dagoro H, Siba PM, Bockarie MJ, Alpers MP, Kazura JW.

PLoS Negl Trop Dis. 2011 Jul;5(7):e1241. doi: 10.1371/journal.pntd.0001241. Epub 2011 Jul 12.

48.

Back to the future: the American Society of Tropical Medicine and Hygiene, its journal and the continuing commitment to global health.

Kazura JW, Ripp J, Milhous WK.

Am J Trop Med Hyg. 2011 Jan;84(1):3-4. doi: 10.4269/ajtmh.2011.10-0666. No abstract available.

49.

Higher-dose, more frequent treatment of Wuchereria bancrofti.

Kazura JW.

Clin Infect Dis. 2010 Dec 1;51(11):1236-7. doi: 10.1086/657064. Epub 2010 Nov 1. No abstract available.

PMID:
21039221
50.

Efficacy model for antibody-mediated pre-erythrocytic malaria vaccines.

White MT, Griffin JT, Riley EM, Drakeley CJ, Moorman AM, Sumba PO, Kazura JW, Ghani AC, John CC.

Proc Biol Sci. 2011 May 7;278(1710):1298-305. doi: 10.1098/rspb.2010.1697. Epub 2010 Oct 13.

Supplemental Content

Loading ...
Support Center